Krsnaa Diagnostics Shareholders Approve Re-Appointment of Executive Chairman

Krsnaa Diagnostics Limited ( (IN:KRSNAA) ) has issued an update.

Krsnaa Diagnostics Limited has secured shareholder approval via postal ballot for the re-appointment of Mr. Rajendra Khivraj Mutha as whole-time director and Executive Chairman for a further five-year term. The resolution was passed with the requisite majority through remote e-voting, reinforcing leadership continuity and governance stability, with detailed voting results and the scrutinizer’s report made available on the company’s website.

This endorsement of Mutha’s continued role as Executive Chairman is expected to support strategic consistency and operational direction at the diagnostics provider, which operates in a competitive and rapidly evolving healthcare market. The outcome signals shareholder confidence in the existing management and may help the company maintain its current trajectory in expanding and managing its diagnostic service network.

More about Krsnaa Diagnostics Limited

Krsnaa Diagnostics Limited operates in the healthcare diagnostics industry, providing diagnostic and laboratory services across India. The company focuses on delivering affordable and accessible diagnostic solutions and is listed on both BSE and the National Stock Exchange under the symbol KRSNAA.

Average Trading Volume: 4,826

Technical Sentiment Signal: Sell

Current Market Cap: 19.6B INR

See more insights into KRSNAA stock on TipRanks’ Stock Analysis page.